2 results
Approved WMOPending
To optimize the quality and cost-effectiveness of care for jaundiced neonates in the Isala Klinieken.
Approved WMOCompleted
Primary Objective:The purpose of Part A is to determine whether sutimlimab administration results in a greater than or equal to (>=)1.5 gram per deciliter (g/dL) increase in hemoglobin (Hgb) level and avoidance of transfusion in participants…